Bavarian Nordic — Juli 2024
-
331 Danish kroner (44.38 euros). Jesper Ilsoe from the Carnegie Group is the most skeptical. He is the only analyst not to recommend buying. His vote is "hold" with a target price of 176 kroner. Bavarian Nordic's share is currently trading at this level."
-
"Bavarian Nordic to reassess? "Increase in Mpox cases expected" 05.07.2024 ‧ Michel Doepke
In Africa, authorities and experts are increasingly watching the spread of Mpox (formerly monkeypox) with concern. According to a South African media report, an increase in Mpox cases is expected as the health department is intensifying the search for contact persons. Bavarian Nordic could help solve the problem with its vaccine.
Four more Mpox cases have occurred in Gauteng and KwaZulu-Natal, reports..
-
the South African news website news24. According to the article, the spokesman for the Ministry of Health, Foster Mohale, said that an increase in cases is to be expected in the coming weeks.
According to the Ministry of Health, the number of Mpox cases is expected to rise as the search for people who have come into contact with people who have tested positive is intensified, news24 continues.
It is not only in South Africa that Mpox is gradually on the rise again. Several Mpox cases have..
-
also recently been reported in the Democratic Republic of Congo.
Bavarian Nordic vaccine in focus
The European vaccine specialist Bavarian Nordic has the right vaccine in its portfolio with MVA-BN (trade names Jynneos or Imvanex) to get the problem under control. The "monkeypox" was already rampant two years ago, which led to enormous demand for the company's vaccine - and caused Bavarian Nordic to be revalued enormously on the stock market.Bavarian Nordic's share currently offers an..
-
attractive risk-reward ratio anyway. The company's travel vaccine portfolio is already benefiting from the global increase in travel enthusiasm. Added to this is the prospect of the company's Chikungunya vaccine being approved. In the short term, the further development of Mpox will of course influence the share price. The AKTIONÄR portfolio is betting on rising prices. If the Mpox situation worsens, the share could quickly jump to a 52-week high. Brave investors are betting on this scenario.
" -
Stærkt @kkjoel - truslen er reel, og nærmest umulig at kontrollere nu, pga strengens større smitsomhed og landets centrale placering, 'The DRC itself reported an increase in the number of cases, with the viral disease now reported in every corner of the country, according to Dr Shungu Lushima, Director of the National Mpox Programme (PNLM) in the DRC.' https://www.theeastafrican.co.ke/tea/science-health/mpox-outbreak-threatens-normal-business-for-dr-congo--4678904
-
'While awaiting the launch of large-scale vaccination, DRC officials and the WHO are concerned about new patterns of sexual transmission of the virus, and the WHO is currently conducting a joint mission with the DRC Ministry of Health "to assess the situation". '
-
..MÅ være et spm om kort tid, før vi ser konsekvensen i form af ordrer til Bava. Tror der kommer flere. Først på den 4. eller 5. får vi en opjustering...imho.
-
..ja, specielt ved clade 1b, den nye variant, som i lige så høj grad rammer kvinder og børn, med 10% dødelighed i børn under 15! Ved udbruddet i 22, clade II, var det jo fortrinsvis MSM segmentet, som var ramt...90-95% af tilfældene.
-
..men du har stadig ret @Strøjer - husker der i 22, at der var et homopar, som havde smittet deres hund, fordi den sov i deres seng, allegedly. Så det er netop virulensen der er steget i den muterede version.
-
Mener det er primært Immunkomprimerede, der bliver hårdt ramt. Der er også en stor del af befolkningen, der har hiv eller er på anden vis svage.. Det farlige nu er, at Mpox er fundet i flytningelejrene på DRC’s østkyst, dvs. truer Rwanda, Burundi og Tanzania, Der delte landegrænse med DRC. Så mpox har allerede spredt ukontrollerede, det er “blot” underrapporteret.
-
..hedder det ikke 'immunkompromitterede'..
-
-
@WorkTrader… jaja… altså… (og tak for genpostning - god artikel.)
-
Er PHEIC-erklæring ikke smart på sin plads? “The strength of PHEIC declarations is the ability to rapidly mobilize international coordination, streamline funding and accelerate the advancement of the development of vaccines, therapeutics and diagnostics under emergency use authorization.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798963/ Eller skal verdenen virkelig igen vente til udbruddet rammer industrialiserede lande? Altså primært hvide befolkningsgrupper...
-
…det var nu ment som et spørgsmål, kære @Cupcake
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind